Dear Spiral user, We’re pleased to introduce Helix, https://helix.imperial.ac.uk/ Imperial’s new repository for research datasets. Please use Helix for all future dataset deposits. There is no change to Spiral - continue depositing as usual. For queries, contact the Research Data Management team at rdm-enquiries@imperial.ac.uk. Kind regards, the Spiral Team. The Spiral team
Predictive factors for alirocumab dose increase in patients with hypercholesterolaemia and high cardiovascular risk: from the ODYSSEY COMBO I and II trials
File(s)
Author(s)
Vallejo-Vaz, AJ
Roth, EM
Hovingh, GK
Louie, MJ
Valcheva, V
Type
Conference Paper
Date Issued
2017-08-29
Date Acceptance
2017-04-19
Citation
European Heart Journal, 2017, 38 (suppl_1, 1 August 2017), pp.1330-1330
URI
DOI
ISSN
1522-9645
Publisher
Oxford University Press (OUP)
Start Page
1330
End Page
1330
Journal / Book Title
European Heart Journal
Volume
38
Issue
suppl_1, 1 August 2017
Copyright Statement
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com.
Source
European Cardiology Society (ESC) Congress 2017
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
1102 Cardiovascular Medicine And Haematology
Cardiovascular System & Hematology
Publication Status
Published
Start Date
2017-08-26
Finish Date
2017-08-30
Coverage Spatial
Barcelona, Spain
Date Publish Online
2017-08-29